Clinical Research Pathways Leadership
Executive Director Marjorie A. Speers, Ph.D.
Marjorie A. Speers, Ph.D., is a global leader in human research protections. Most recently, she was founding president and CEO of the Association for the Accreditation of Human Research Protection Programs, Inc. (AAHRPP), retiring in 2013. Dr. Speers views the opportunity to lead this public charity—and continue to advance high-quality, ethical research—as the natural progression in an exemplary career of public service. Before establishing AAHRPP in 2001, she served as acting executive director of the National Bioethics Advisory Commission. At the Centers for Disease Control and Prevention, she oversaw research protections for all domestic and international research. Dr. Speers is a graduate of Dickinson College, where she serves on the Board of Trustees and established a scholarship that has benefited numerous international students. She also holds doctoral degrees in psychology and epidemiology from Yale University.
Board of Directors
Peter F. Buckley, M.D.
Dean School of Medicine, Virginia Commonwealth University Executive Vice President, Medical Affairs Virginia Commonwealth University Health System
Anne B. Cropp, Pharm.D., BCAP
Founder and Chief Scientific Officer
Early Access Care
Dr. Anne B. Cropp is founder and Chief Scientific Officer of Early Access Care, a healthcare firm that helps biopharmaceutical companies develop and implement programs for expanded access/compassionate use of investigational drugs. A globally recognized expert in early access/expanded access/compassionate use, Dr. Cropp collaborates with biopharmaceutical companies, global health authorities, and academic thought leaders on issues pertaining to adult and pediatric expanded access programs. She has presented at and chaired several international scientific symposia on early access and managed access.
Dr. Cropp has 25 years of experience in pharmaceutical and biopharmaceutical drug development, in a career distinguished by global leadership and achievements in innovation. Prior to founding Early Access Care, she was Vice President in the Global Product Development Group of Pfizer, Inc., where she also served as chair of the Pfizer Pediatric Council.
She has been responsible for the strategic planning, development, and execution of investigational drugs across a broad spectrum of diseases, including Alzheimer’s disease, heart failure, hypercholesterolemia, hypertension, and type 1 and type 2 diabetes mellitus. Dr. Cropp also has extensive expertise in drug development for pediatric and adult patients.
A pharmacist and board-certified clinical pharmacologist, Dr. Cropp earned a Bachelor of Science in pharmacy from Massachusetts College of Pharmacy and a Doctor of Pharmacy degree from Duquesne University. For her work on naloxone as a treatment for ischemic stroke, Dr. Cropp received the Roche Young Investigator Award. She completed a post-doctoral research fellowship in cardiovascular pharmacology at the Millard Fillmore Hospital in Buffalo, New York, and was an adjunct faculty member at the State University of New York at Buffalo. In addition, Dr. Cropp was a National Institutes of Health Fogarty Fellow at the National Heart, Lung, and Blood Institute.
Her decision to found Early Access Care is rooted in her experience as a longstanding member of the scientific research community and her desire to help patients and advance their care.
David Farber, J.D.
Partner, FDA/Life Sciences Practice King & Spalding
Angelike A. Giallourakis, Ph.D.
President Steven G. AYA Cancer Research Fund
Founder and Executive Director
The Isaac Foundation
Equal Access for Rare Disorders
Andrew McFadyen is the founder and Executive Director of two nonprofit organizations that help patients and families who are dealing with rare diseases.
The Isaac Foundation funds innovative research that seeks to find a cure for the mucopolysaccharidoses (MPS), a group of devastating, debilitating metabolic disorders. Mr. McFadyen’s oldest son, Isaac, has MPS VI. A second organization, Equal Access for Rare Disorders, works to ensure access to lifesaving treatments, both approved and in development, for patients with rare diseases. Both organizations are based in Campbellford, Ontario, Canada.
Mr. McFadyen has led advocacy efforts on behalf of patients throughout North America and has helped shape Canada’s public policy on providing government funding for cost-prohibitive treatments for children who are dying of rare diseases. A vocal opponent of “right to try laws” that weaken patient protections by bypassing the Food and Drug Administration, Mr. McFadyen has had articles published in Alaska’s online newspaper, Juneau Empire; on the U.S. political website, The Hill; and The Health Care Blog. He testified at a U.S. congressional hearing on right to try legislation.
Mr. McFadyen is a member of the NYU Langone Health Working Group on Compassionate Use and Pre-Approval Access (CUPA). He also is an associate fellow of the GE2P2 Global Foundation, which aims to advance scientific rigor and ethical research in evidence generation. He holds Bachelor of Arts and Bachelor of Education degrees from Queen’s University in Ontario.
Rev. Dr. Jason E. Owen, S.T.D.
Founder, Chief Apostle, and International Presiding Bishop
Biblical Deliverance Ministries, Inc.
Rev. Dr. Jason E. Owen has championed health equity and diversity throughout his career. A community activist and spiritual leader, he has worked tirelessly to improve access to healthcare and quality of life for Georgia’s underserved.
Currently, Rev. Dr. Owen is Chief Apostle and International Presiding Bishop of Biblical Deliverance Ministries, which he founded in Snellville, Georgia, in 1998. He is the Spiritual Care and Bereavement Care Coordinator of Dynamic Hospice in Decatur, Georgia; a member of the Community Advisory Board of the Clinical Research Center at Morehouse School of Medicine in Atlanta; and on the Health Committee of the Concerned Black Clergy of Metropolitan Atlanta.
In addition, Rev. Dr. Owen serves as Dean of the Gathering of the Eagles College of Apostles and Bishops Congress International and Co-Presider of Broken Vessel Alliance International Fellowship of Ministries and Churches, both in Powder Springs, Georgia.
Previously, Rev. Dr. Owen served as a co-facilitator for the Atlanta chapter of the “Healthy Brain Initiative State and Local Public Health Partnerships to Address Dementia,” a joint effort of the Alzheimer’s Association and Centers for Disease Control and Prevention. He also was a community liaison for the VITAS Access Initiative of VITAS Healthcare in Atlanta and Chair of the Executive Board of Caregivers’ Hope, also in Atlanta.
A native of Guyana, Rev. Dr. Owen holds master’s degrees in religious education and theology, and a Sacred Theological Doctorate, all from United Christian College in Queens, New York.
Joanne Waldstreicher, M.D.
Chief Medical Officer Johnson & Johnson